Fetuin A is an endogenous inhibitor of the insulin receptor tyrosine kinase in muscle [75], while IGFBP1 is a modulator of insulin-like growth factor 1 (IGF-1) action associated with hyperinsulinemia and glucose intolerance [76]. Here, IGF1 is linked to Hyperinsulinemia.